Crystal structure of calcium bound domain VI of calpain at 1.9 angstrom resolution and its role in enzyme assembly, regulation, and inhibitor binding

被引:179
作者
Lin, GD
Chattopadhyay, D
Maki, M
Wang, KKW
Carson, M
Jin, L
Yuen, P
Takano, E
Hatanaka, M
DeLucas, LJ
Narayana, SVL
机构
[1] UNIV ALABAMA, CTR MACROMOL CRYSTALLOG, BIRMINGHAM, AL 35294 USA
[2] NAGOYA UNIV, SCH AGR, NAGOYA, AICHI 464, JAPAN
[3] WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, NEUROSCI THERAPEUT, MORRIS PLAINS, NJ 07950 USA
[4] KYOTO UNIV, INST VIRUS RES, KYOTO 606, JAPAN
[5] WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, MED CHEM, MORRIS PLAINS, NJ 07950 USA
[6] UNIV ALABAMA, SCH OPTOMETRY, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1038/nsb0797-539
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three dimensional structure of calcium-bound domain VI of porcine calpain has been determined to 1.9 Angstrom resolution. The crystal structure reveals five EF-hands, one more than previously suggested. There are two EF-hand pairs, one pair (EF1-EF2) displays an 'open' conformation and the other (EF3-EF4) a 'closed' conformation. Unusually, a calcium atom is found at the C-terminal end of the calcium binding loop of EF4. With two additional residues in the calcium binding loop, the fifth EF-hand (EF5) is in a 'closed' conformation. EF5 pairs up with the corresponding fifth EF-hand of a non-crystallographically related molecule. Considering the EF5's role in a homodimer formation of domain VI, we suggest a model for the assembly of heterodimeric calpain. The crystal structure of a Ca2+ bound domain VI-inhibitor (PD150606) complex has been refined to 2.1 Angstrom resolution. A possible mode for calpain inhibition is discussed.
引用
收藏
页码:539 / 547
页数:9
相关论文
共 54 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   CALPAIN INHIBITOR AK295 PROTECTS NEURONS FROM FOCAL BRAIN ISCHEMIA - EFFECTS OF POSTOCCLUSION INTRAARTERIAL ADMINISTRATION [J].
BARTUS, RT ;
HAYWARD, NJ ;
ELLIOTT, PJ ;
SAWYER, SD ;
BAKER, KL ;
DEAN, RL ;
AKIYAMA, A ;
STRAUB, JA ;
HARBESON, SL ;
LI, Z ;
POWERS, J .
STROKE, 1994, 25 (11) :2265-2270
[3]  
Brunger A.T., 1992, X-Plor Manual Version 3.1
[4]   CA2+-SPECIFIC REMOVAL OF Z LINES FROM RABBIT SKELETAL-MUSCLE [J].
BUSCH, WA ;
SUZUKI, A ;
STROMER, MH ;
GOLL, DE .
JOURNAL OF CELL BIOLOGY, 1972, 52 (02) :367-&
[5]   COMPARISON OF HOMOLOGY MODELS WITH THE EXPERIMENTAL STRUCTURE OF A NOVEL SERINE-PROTEASE [J].
CARSON, M ;
BUGG, CE ;
DELUCAS, LJ ;
NARAYANA, SVL .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1994, 50 :889-899
[6]   AN ASSESSMENT OF THE EFFECT OF THE HELIX DIPOLE IN PROTEIN STRUCTURES [J].
CHAKRABARTI, P .
PROTEIN ENGINEERING, 1994, 7 (04) :471-474
[7]   Methionine to glutamine substitutions in the C-terminal domain of calmodulin impair the activation of three protein kinases [J].
Chin, D ;
Means, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30465-30471
[8]   DRUG-BINDING BY CALMODULIN - CRYSTAL-STRUCTURE OF A CALMODULIN TRIFLUOPERAZINE COMPLEX [J].
COOK, WJ ;
WALTER, LJ ;
WALTER, MR .
BIOCHEMISTRY, 1994, 33 (51) :15259-15265
[9]  
COOLICAN SA, 1986, J BIOL CHEM, V261, P4170
[10]   CALCIUM-BINDING INDUCES CONFORMATIONAL-CHANGES IN MUSCLE REGULATORY PROTEINS [J].
DASILVA, ACR ;
REINACH, FC .
TRENDS IN BIOCHEMICAL SCIENCES, 1991, 16 (02) :53-57